US OptionsDetailed Quotes
VUZI241220P2000
- 0.30
- +0.05+20.00%
15min DelayClose Nov 27 16:00 ET
0.30High0.20Low
0.25Open0.25Pre Close30 Volume237 Open Interest2.00Strike Price732.00Turnover128.49%IV20.19%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type-0.3578Delta0.5484Gamma10.65Leverage Ratio-0.0056Theta-0.0005Rho-3.81Eff Leverage0.0020Vega
Vuzix Stock Discussion
Sign in to post a comment
$Vuzix (VUZI.US)$ Vuzix to Showcase Full Color, State-of-the-Art, See-Through, Waveguide-Based Smart Glasses Designs at Upcoming CES 2025 Event
3 minutes ago, 8:07 AM EST
Via PR Newswire
3 minutes ago, 8:07 AM EST
Via PR Newswire
1
7
$Vuzix (VUZI.US)$
Vuzix to Showcase Full Color, State-of-the-Art, See-Through, Waveguide-Based Smart Glasses Designs at Upcoming CES 2025 Event
Vuzix (NASDAQ: VUZI) has announced its participation in CES 2025 (January 7-10, 2024) where it will showcase new waveguide technologies and smart glasses designs. The company will display its new full-color 1.0mm thin waveguideand a super-slim 0.7mm waveguide, alongside various display engines including µLEDs and LCoS projectors. Multiple new OEM Ul...
Vuzix to Showcase Full Color, State-of-the-Art, See-Through, Waveguide-Based Smart Glasses Designs at Upcoming CES 2025 Event
Vuzix (NASDAQ: VUZI) has announced its participation in CES 2025 (January 7-10, 2024) where it will showcase new waveguide technologies and smart glasses designs. The company will display its new full-color 1.0mm thin waveguideand a super-slim 0.7mm waveguide, alongside various display engines including µLEDs and LCoS projectors. Multiple new OEM Ul...
1
I WILL UPDATE IF I FIND MORE
$Poseida Therapeutics (PSTX.US)$ ✔️TOP PLAY. To be acquired by Roche for $1.5B for $9.00/share. “Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash”
$Citius Pharmaceuticals (CTXR.US)$✔️ News halt after hours + PR today o...
$Poseida Therapeutics (PSTX.US)$ ✔️TOP PLAY. To be acquired by Roche for $1.5B for $9.00/share. “Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash”
$Citius Pharmaceuticals (CTXR.US)$✔️ News halt after hours + PR today o...
40
11
$Vuzix (VUZI.US)$
Vuzix Receives Production Order for Customized Waveguides from a Major Defense Customer
Vuzix (NASDAQ: VUZI) has secured a six-figure production order for customized waveguides from a major US-based aerospace and defense industry leader. The waveguides will be used to create a lightweight heads-up display (HUD). The customer, who is described as an incumbent supplier for several existing programs, has chosen Vuzix specifically as a US-based manufacturer of waveguide and disp...
Vuzix Receives Production Order for Customized Waveguides from a Major Defense Customer
Vuzix (NASDAQ: VUZI) has secured a six-figure production order for customized waveguides from a major US-based aerospace and defense industry leader. The waveguides will be used to create a lightweight heads-up display (HUD). The customer, who is described as an incumbent supplier for several existing programs, has chosen Vuzix specifically as a US-based manufacturer of waveguide and disp...
1
2
$Vuzix (VUZI.US)$ Lets do it quietly 🤫🤫🤫
2
$Vuzix (VUZI.US)$ Its coming ‼
$Vuzix (VUZI.US)$ This is the future. I keep buy the dip, hold for long term 2-3 years.
2
$Vuzix (VUZI.US)$
Vuzix M-Series Smart Glasses Now Certified for Use with Microsoft Intune
Vuzix (NASDAQ: VUZI) announced that its M-series AR smart glasses have been certified for use with Microsoft Intune, a leading cloud-based Mobile Device Management solution. This certification enables organizations to manage and secure their M400 and M4000 AR smart glasses from a central location. Microsoft Intune provides control over device settings, application access, and security policies while ...
Vuzix M-Series Smart Glasses Now Certified for Use with Microsoft Intune
Vuzix (NASDAQ: VUZI) announced that its M-series AR smart glasses have been certified for use with Microsoft Intune, a leading cloud-based Mobile Device Management solution. This certification enables organizations to manage and secure their M400 and M4000 AR smart glasses from a central location. Microsoft Intune provides control over device settings, application access, and security policies while ...
No comment yet
103773561 : why??now it going down..
104481232 : A sudden drop is so scary.
Trytosaveabit OP 103773561 : Looks like a short attack or SL hunt to me?
103773561 : should i stay?![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Trytosaveabit OP 103773561 : Sorry I don’t give buy / sell advice! I have no way to know peoples risk tolerance or type of trade they are doing! Hope you understand? GL
View more comments...